NIH-funded research R01 grant

Improving HIV testing and prevention in Sub-Saharan Africa using rapid tests.

Official title: Rapid Tests for Recent Infection (RTRI) for Precision Public Health in Sub-Saharan Africa: Next-Generation Strategies Amid Changing HIV Epidemiology

Funded at New York University School of Medicine · NIH-10977062 · Data updated 2026-11-12

This study is looking at how quick tests for recent HIV infections can help improve testing and prevention efforts in Sub-Saharan Africa, making sure that support and resources go to those who need it most.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startNovember 4, 2022
Project endOctober 31, 2027
Funding year2025
Award (this year)$720,426
NIH project number5R01AI174932-03
Project IDNIH-10977062 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals aged 21 and older living in Sub-Saharan Africa who may be at risk for HIV infection.

Less likely to help

Patients who are not at risk for HIV infection or who are already receiving effective treatment may not benefit from this research.

What this research studies

This research focuses on enhancing HIV testing and prevention strategies in Sub-Saharan Africa by utilizing rapid tests for recent HIV infections. These tests can quickly identify individuals who have been recently infected, allowing for targeted public health responses. By implementing a precision public health approach, the research aims to improve the efficiency of HIV services, ensuring that resources are allocated where they can have the greatest impact. The study will analyze the effectiveness of these rapid tests in real-time to better control the HIV epidemic in the region.

Why it matters

Potential benefit: If successful, this research could lead to more effective HIV prevention and testing strategies, ultimately reducing new infections in Sub-Saharan Africa.

How similar studies have gone: Other research has shown promise in using rapid tests for recent infections, indicating that this approach could be effective in improving HIV response strategies.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Bershteyn, Anna — New York University School of Medicine
  • Study coordinator: Bershteyn, Anna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.